MX2022016012A - Polipéptidos de unión al receptor de la il-23 humana. - Google Patents

Polipéptidos de unión al receptor de la il-23 humana.

Info

Publication number
MX2022016012A
MX2022016012A MX2022016012A MX2022016012A MX2022016012A MX 2022016012 A MX2022016012 A MX 2022016012A MX 2022016012 A MX2022016012 A MX 2022016012A MX 2022016012 A MX2022016012 A MX 2022016012A MX 2022016012 A MX2022016012 A MX 2022016012A
Authority
MX
Mexico
Prior art keywords
human
receptor binding
binding polypeptides
polypeptides
binding proteins
Prior art date
Application number
MX2022016012A
Other languages
English (en)
Inventor
David Baker
Stephanie Berger
Franziska Seeger
Ta-Yi Yu
Original Assignee
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Washington filed Critical Univ Washington
Publication of MX2022016012A publication Critical patent/MX2022016012A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente divulgación proporciona polipéptidos de unión a la IL-23R humana (hIL-23R), proteínas de unión a la hIL-23R condicionalmente activadas al máximo, multímeros de las mismas, y métodos para utilizar los polipéptidos y las proteínas de unión para uso terapéutico.
MX2022016012A 2020-06-29 2021-06-25 Polipéptidos de unión al receptor de la il-23 humana. MX2022016012A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063045381P 2020-06-29 2020-06-29
PCT/US2021/039122 WO2022005899A1 (en) 2020-06-29 2021-06-25 Human il23 receptor binding polypeptides

Publications (1)

Publication Number Publication Date
MX2022016012A true MX2022016012A (es) 2023-03-10

Family

ID=76959124

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022016012A MX2022016012A (es) 2020-06-29 2021-06-25 Polipéptidos de unión al receptor de la il-23 humana.

Country Status (11)

Country Link
US (1) US20230357323A1 (es)
EP (1) EP4172183A1 (es)
JP (1) JP2023531771A (es)
KR (1) KR20230030649A (es)
CN (1) CN115916810A (es)
AU (1) AU2021301192A1 (es)
BR (1) BR112022026700A2 (es)
CA (1) CA3183027A1 (es)
IL (1) IL299529A (es)
MX (1) MX2022016012A (es)
WO (1) WO2022005899A1 (es)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013507124A (ja) * 2009-10-09 2013-03-04 アナフォア インコーポレイテッド Ｉｌ−２３ｒを結合するポリペプチド
CN113563423A (zh) * 2014-07-17 2021-10-29 领导医疗有限公司 白细胞介素-23受体的口服肽抑制剂以及其治疗炎症性肠病的用途

Also Published As

Publication number Publication date
JP2023531771A (ja) 2023-07-25
CN115916810A (zh) 2023-04-04
IL299529A (en) 2023-02-01
KR20230030649A (ko) 2023-03-06
US20230357323A1 (en) 2023-11-09
WO2022005899A1 (en) 2022-01-06
EP4172183A1 (en) 2023-05-03
AU2021301192A1 (en) 2023-02-02
BR112022026700A2 (pt) 2023-01-24
CA3183027A1 (en) 2022-01-06

Similar Documents

Publication Publication Date Title
CA3010621A1 (en) Molecules that selectively activate regulatory t cells for the treatment of autoimmune diseases
AU2018274216A1 (en) Antibody-cytokine engrafted proteins and methods of use in the treatment of cancer
PH12020500648A1 (en) Il-15 variants and uses thereof
WO2019222275A3 (en) Compositions and methods for tcr reprogramming using inducible fusion proteins
EA201992063A1 (ru) СВЯЗЫВАЮЩИЕ ErbB-2 И ErbB-3 БИСПЕЦИФИЧЕСКИЕ АНТИТЕЛА ДЛЯ ПРИМЕНЕНИЯ ДЛЯ ЛЕЧЕНИЯ КЛЕТОК, КОТОРЫЕ СОДЕРЖАТ СЛИТЫЙ ГЕН NRG-1
MX344559B (es) Compuestos de hormona de crecimiento humana recombinante unidos al peg.
ZA200604605B (en) Antibodies that bind interleukin-4 receptor
GB0713656D0 (en) Modified human growth hormone
SI1641483T1 (sl) Fuzijski proteini
TW200531679A (en) Methods of modulating cytokine activity; related reagents
EP2283860A3 (en) Use for interleukin-33 (il-33) and the il-33 receptor complex
MX2019015477A (es) Proteinas de union a antigeno del virus del papiloma anti-humano (vph) y metodos de uso de las mismas.
HK1131790A1 (en) High affinity human antibodies to human il-4 receptor
WO2020057541A8 (en) Anti-ifnar1 antibodies for treating autoimmune diseases
NZ746784A (en) Glucagon and glp-1 co-agonists for the treatment of obesity
MX2020006822A (es) Proteinas de fusion de anticuerpo de un solo dominio-citosina desaminasa.
WO2018115432A3 (en) COMPOUNDS FOR THE TREATMENT OF BOVINE OR PORCINE RESPIRATORY DISEASE
IL189452A0 (en) Therapy with cd4 binding peptides and radiation
MX2007004861A (es) Derivados de sulfonamida novedosos como moduladores de receptor glucocorticoide para el tratamiento de enfermedades inflamatorias.
EP3735458A4 (en) RECOMBINANT HUMAN SIALIDASES, SIALIDASE FUSION PROTEINS AND METHODS OF USE THEREOF
JOP20220071A1 (ar) سيتوكين مناعي يشمل معقد بروتين دايمري غير متجانس على أساس IL-15/IL-15Ra
MX2021001508A (es) Proteínas de unión multiespecífica que se unen a her2, nkg2d y cd16 y métodos de uso.
MX2020012273A (es) Proteína de union a nkg2d, cd16 y proteína de activación de fibroblastos.
EP4048224A4 (en) THERAPEUTIC COMPRESSION APPARATUS, SYSTEM AND METHODS OF USE
EP3994275A4 (en) RECOMBINANT HUMAN SIALIDASES, SIALIDASE FUSION PROTEINS AND METHODS OF USE THEREOF